Beacon DDR Database

Leverage Beacon DDR’s unique searching ontologies to run the most accurate searches for DDR drugs & trials based on the target, repair pathway, synthetic lethality info, disease & phase, all tagged by a team of DDR analysts to remove the burden of keyword searching

Access all preclinical & clinical data for both single agent & combination therapies in one place, curated by our team of DDR analysts to the level of preclinical animal models, clinical toxicity, overall response, PFS & beyond, to quickly understand where your data differentiates with confidence

Use Beacon’s proprietary clinical trial searching filters to run highly targeted combination searches across DDR trials in combination with other modalities such as checkpoint modulators, with the ability to filter by biomarkers & key clinical readouts such as PK data, overall response, and progression free survival

Take advantage of our comprehensive modality tagging within Beacon DDR & our other datasets such as ADCs, Bispecifics, and Oncology to laser in on successful strategies & access curated clinical design data points.

Bulletproof your DDR investment strategy by confidently communicating your position in the market to investors & potential partners, with well benchmarked science, allowing you to stand out in a competitive market using robust data from Beacon.

Beacon helps developers stand out by providing comprehensive insights into targets, diseases & combination strategies & enhances your ability to attract investors and secure the capital needed to take your DDR drug to the next phase.

Optimize your DDR partnership strategy by identifying new prospect companies or competitors as soon as they enter the field, taking advantage of Beacon’s unique approach to capturing early-stage companies and curated insights on deals & pipelines all in one place.